Seaport Therapeutics, Inc. Common Stock (SPTX) Stock Overview
Explore Seaport Therapeutics, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.
Seaport Therapeutics, Inc. Common Stock (SPTX)
Key Financials
Key Financials
Market Cap
1.1B
P/E Ratio
-12.89
EPS (TTM)
$-2.52
ROE
-0.57%
SPTX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Seaport Therapeutics, Inc. Common Stock (NASDAQ: SPTX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Seaport Therapeutics, Inc. Common Stock's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SPTX on the NASDAQ shows an RSI of 40.93, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $21.55 for the NASDAQ listing.
Key metrics behind Seaport Therapeutics, Inc. Common Stock's NASDAQ-traded stock include a P/E ratio of -12.89 and a market capitalization of 1.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of SPTX on the NASDAQ.